Search research articles
Contact Us
Filters
Showing results (331-340 of 703) with videos related to
Page
of 71
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2012
Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition
Lisa Zimmer, Uwe Hillen, Elisabeth Livingstone, et al.
The Journal of Clinical Investigation
|
May 29, 2014
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
Jamie N Anastas, Rima M Kulikauskas, Tigist Tamir, et al.
The Journal of Clinical Investigation
|
November 20, 2025
Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans
Linda Wu, John M Wentworth, Christopher Liddle, et al.
Psycho-Oncology
|
December 18, 2024
Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods Study
Kathy Dempsey, Robyn Saw, Iris Bartula, et al.
Cancer Immunology Research
|
August 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
F Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, et al.
Pathology
|
March 30, 2016
The molecular profile of metastatic melanoma in Australia
Megan Lyle, Lauren E Haydu, Alexander M Menzies, et al.
The Journal of Investigative Dermatology
|
September 23, 2014
Epigenetic changes of EGFR have an important role in BRAF inhibitor-resistant cutaneous melanomas
Jinhua Wang, Sharon K Huang, Diego M Marzese, et al.
Journal of Translational Medicine
|
May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021
Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.
Frontiers in Immunology
|
June 28, 2021
<i>PDCD1</i> Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma
Sagun Parakh, Ashan Musafer, Sabrina Paessler, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2020
Efficacy of immune checkpoint inhibitors for in-transit melanoma
Emilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, et al.
Page
of 71
Search research articles
Search
Showing results (331-340 of 703) with videos related to
Sort By:
Page
of 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2012
Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition
Lisa Zimmer, Uwe Hillen, Elisabeth Livingstone, et al.
The Journal of Clinical Investigation
|
May 29, 2014
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
Jamie N Anastas, Rima M Kulikauskas, Tigist Tamir, et al.
The Journal of Clinical Investigation
|
November 20, 2025
Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans
Linda Wu, John M Wentworth, Christopher Liddle, et al.
Psycho-Oncology
|
December 18, 2024
Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods Study
Kathy Dempsey, Robyn Saw, Iris Bartula, et al.
Cancer Immunology Research
|
August 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
F Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, et al.
Pathology
|
March 30, 2016
The molecular profile of metastatic melanoma in Australia
Megan Lyle, Lauren E Haydu, Alexander M Menzies, et al.
The Journal of Investigative Dermatology
|
September 23, 2014
Epigenetic changes of EGFR have an important role in BRAF inhibitor-resistant cutaneous melanomas
Jinhua Wang, Sharon K Huang, Diego M Marzese, et al.
Journal of Translational Medicine
|
May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021
Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.
Frontiers in Immunology
|
June 28, 2021
<i>PDCD1</i> Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma
Sagun Parakh, Ashan Musafer, Sabrina Paessler, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2020
Efficacy of immune checkpoint inhibitors for in-transit melanoma
Emilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, et al.
Page
of 71